Martin P J
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Bone Marrow Transplant. 1991 Sep;8(3):217-23.
Patients transplanted with marrow from an HLA-phenotypically identical unrelated donor have a much higher risk of acute graft-versus-host disease (GVHD) than patients transplanted from an HLA-genotypically identical sibling. Much of this increased risk may be due to disparity for antigens encoded by genes within the MHC. Although the development of molecular genetic methods for HLA-typing may enable better matching between unrelated donor/recipient pairs, the extent to which GVHD risk might be decreased remains uncertain because disparity for minor histocompatibility antigens encoded by genes outside the MHC also causes GVHD. By application of fundamental population genetics, it can be demonstrated that the disparity for minor histocompatibility antigens is substantially greater between unrelated individuals than between family members. These findings imply that even with improved HLA-matching, unrelated marrow transplantation will carry more risk of GVHD than transplantation from a related donor.
接受来自 HLA 表型相同的无关供体骨髓移植的患者,发生急性移植物抗宿主病(GVHD)的风险比接受来自 HLA 基因型相同的同胞移植的患者高得多。这种风险增加的很大一部分可能归因于 MHC 内基因编码抗原的差异。尽管 HLA 分型分子遗传学方法的发展可能使无关供体/受体对之间的匹配更好,但由于 MHC 外基因编码的次要组织相容性抗原的差异也会导致 GVHD,GVHD 风险可能降低的程度仍不确定。通过应用基本群体遗传学,可以证明无关个体之间次要组织相容性抗原的差异比家庭成员之间大得多。这些发现意味着,即使 HLA 匹配得到改善,无关供体骨髓移植比相关供体移植仍将承担更高的 GVHD 风险。